Fingerprint
Dive into the research topics of 'The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically